Mohammed Abdul Jawad

9 months ago · 1 min. reading time · visibility 0 ·

chat Contact the author

thumb_up Relevant message Comment

COVID-19 Prevention Measures for Those Working in GMP Pharmaceuticals and Healthcare Facilities

COVID-19 Prevention Measures for Those Working in GMP Pharmaceuticals and Healthcare Facilities

COVID-19 Prevention Measures for Those Working in GMP Pharmaceuticals and Healthcare Facilities

To view this webinar on demand please click here. 

Learning Outcomes:

  • What is coronavirus?
  • Relative risks
  • Transmission vectors
  • Temperature and general hygiene assessments
  • PPE – what works (and what doesn’t)
  • Guidance for working in cleanrooms
  • Risks of coronavirus in relation to HEPA filters
  • Which are the best disinfectants to kill coronavirus?

To download the associated Whitepaper "Considerations of COVID-19 Prevention Measures for those working in GMP Pharmaceuticals and Healthcare Facilities" please click here.

Introduction from the associated whitepaper:


COVID-19 is continuing to have a global impact, with infection numbers rising daily. It is caused by the virus SARS-CoV-2 (Severe Acute Respiratory Syndrome coronavirus 2) and transfer occurs due to close contact with an infected person, by exposure to coughing, sneezing, breathing in droplets, or airborne particles, or from touching contaminated surfaces. 


This white paper focuses on the risk posed to GMP facilities in pharmaceuticals and healthcare, in terms of keeping employees safe and ensuring the continuity of supply of medicines. 


The white paper includes a brief overview of the coronavirus, its modes of transmission and the risks posed to individuals. The paper then proceeds to consider some key topics, including general personnel safety, face masks and other protective equipment, cleaning and disinfection, general cleanroom operational risks and factors to enhance room protection in terms of HEPA filtration together with temperature and humidity controls. 


Because of the risks concerning the virus and its multiple modes of infection, this paper only includes generalized advice. Additional information may need to be sought when considering a COVID-19 safety strategy for a pharmaceutical or healthcare establishment and the references provided (along with other sources) should be consulted.


To view this webinar on demand please click here. 


To download the associated Whitepaper "Considerations of COVID-19 Prevention Measures for those working in GMP Pharmaceuticals and Healthcare Facilities" please click here.


Source: rssl - science with services

thumb_up Relevant message Comment
Comments

More articles from Mohammed Abdul Jawad

View blog
1 day ago · 2 min. reading time
Mohammed Abdul Jawad

Embracing Digital Transformation through Internal Communications

FREE WEBINAR · When: Monday, 25 October 2021 · Tim ...

3 months ago · 3 min. reading time
Mohammed Abdul Jawad

Principles of Engineering

FREE COURSE - FREE CERTIFICATE · FREE ONLINE COURS ...

3 months ago · 1 min. reading time
Mohammed Abdul Jawad

Wellness Challenge Ideas

WellRight’s wellness activities and challenge idea ...